Rangaraj Selvarangan, BVSc, PhD, D(ABMM), FIDSA, FAAM

Director
Children’s Mercy Kansas City

Disclosure(s): Abbott: Grant/Research Support, Honoraria; BioMerieux: Grant/Research Support; Cepheid: Grant/Research Support; Diasorin: Grant/Research Support; GSK: Advisor/Consultant; Hologic: Grant/Research Support; Luminex: Grant/Research Support; Qiagen: Grant/Research Support

Poster(s):

(P-670) Differences in Adenovirus Type Detection in Children with Acute Respiratory Illness versus Healthy Controls: New Vaccine Surveillance Network (NVSN) 2016-2019

Thursday, October 17, 2024
12:15 PM – 1:30 PM US PT
(P-1203) Acute Respiratory Viral Infections in Children with Malignancy in the CDC New Vaccine Surveillance Network, 2016–2020

Friday, October 18, 2024
12:15 PM – 1:30 PM US PT
(P-1209) Changes in Antiviral Prescription for Children with Influenza in U.S. Emergency Departments During the COVID-19 Pandemic: New Vaccine Surveillance Network (NVSN), 2016-2023

Friday, October 18, 2024
12:15 PM – 1:30 PM US PT
(P-1945) Genomic Surveillance of SARS-CoV-2 Variants among Children Enrolled in the New Vaccine Surveillance Network (NVSN) - Kansas City

Saturday, October 19, 2024
12:15 PM – 1:30 PM US PT
(P-2171) Comparing Saliva and Nasal Mid-turbinate Swabs for Detection of Respiratory Syncytial Virus (RSV), February 1–April 15, 2024, New Vaccine Surveillance Network

Saturday, October 19, 2024
12:15 PM – 1:30 PM US PT
(P-2329) Diversity of Rhinovirus Types in Children During the COVID-19 Pandemic, New Vaccine Surveillance Network, 03/01/20-02/28/21

Saturday, October 19, 2024
12:15 PM – 1:30 PM US PT
(P-2358) Viral etiologies of bronchiolitis, pneumonia, and croup in children less than 5 years old, New Vaccine Surveillance Network, 2016-2022

Saturday, October 19, 2024
12:15 PM – 1:30 PM US PT
(P-2366) Influenza-Specific Antiviral Use in Hospitalized Children Before and During the COVID-19 Pandemic, New Vaccine Surveillance Network (2016–2023)

Saturday, October 19, 2024
12:15 PM – 1:30 PM US PT